PlainRecalls
FDA Drug Moderate Class II Terminated

Lamotrigine Tablets, USP, 200 mg, packaged in a) 60-count bottles (NDC 0378-4254-91) and b) 500-count bottles (NDC 0378-4254-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

Reported: November 13, 2013 Initiated: September 13, 2013 #D-66403-003

Product Description

Lamotrigine Tablets, USP, 200 mg, packaged in a) 60-count bottles (NDC 0378-4254-91) and b) 500-count bottles (NDC 0378-4254-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

Reason for Recall

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Details

Units Affected
28,140 bottles
Distribution
Nationwide and Puerto Rico
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Lamotrigine Tablets, USP, 200 mg, packaged in a) 60-count bottles (NDC 0378-4254-91) and b) 500-count bottles (NDC 0378-4254-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 28,140 bottles.
Why was this product recalled?
CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2013. Severity: Moderate. Recall number: D-66403-003.